EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H32O5 |
| Net Charge | 0 |
| Average Mass | 376.493 |
| Monoisotopic Mass | 376.22497 |
| SMILES | CC/C=C\C[C@@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(=O)O |
| InChI | InChI=1S/C22H32O5/c1-2-3-9-14-19(23)15-10-6-4-5-7-11-16-20(24)21(25)17-12-8-13-18-22(26)27/h3-12,15-16,19-21,23-25H,2,13-14,17-18H2,1H3,(H,26,27)/b6-4-,7-5+,9-3-,12-8-,15-10+,16-11+/t19-,20-,21+/m1/s1 |
| InChIKey | OIWTWACQMDFHJG-BJEBZIPWSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Homo sapiens (ncbitaxon:9606) | - | PubMed (17244615) |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antiviral agent A substance that destroys or inhibits replication of viruses. TGFbeta receptor antagonist An antagonist that binds to and deactivates TGFβ receptors. human xenobiotic metabolite Any human metabolite produced by metabolism of a xenobiotic compound in humans. specialised pro-resolving mediator A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation. |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-allergic agent A drug used to treat allergic reactions. nephroprotective agent Any protective agent that is able to prevent damage to the kidney. specialised pro-resolving mediator A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role analgesic (CHEBI:35480) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role anti-allergic agent (CHEBI:50857) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role anti-inflammatory agent (CHEBI:67079) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role antiviral agent (CHEBI:22587) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role human xenobiotic metabolite (CHEBI:76967) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role nephroprotective agent (CHEBI:76595) |
| aspirin-triggered resolvin D1 (CHEBI:138179) has role TGFβ receptor antagonist (CHEBI:91202) |
| aspirin-triggered resolvin D1 (CHEBI:138179) is a hydroxy polyunsaturated fatty acid (CHEBI:140345) |
| aspirin-triggered resolvin D1 (CHEBI:138179) is a resolvin (CHEBI:132120) |
| aspirin-triggered resolvin D1 (CHEBI:138179) is a secondary allylic alcohol (CHEBI:134396) |
| IUPAC Name |
|---|
| (4Z,7S,8R,9E,11E,13Z,15E,17R,19Z)-7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid |
| Synonyms | Source |
|---|---|
| 17-epi-resolvin D1 | ChEBI |
| 17(R)-resolvin D1 | ChEBI |
| 17(R)-RvD1 | ChEBI |
| (4Z,7S,8R,9E,11E,13Z,15E,17R,19Z)-7,8,17-trihydroxydocosahexaenoic acid | ChEBI |
| 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid | LIPID MAPS |
| AT-Resolvin D1 | LIPID MAPS |
| Manual Xrefs | Databases |
|---|---|
| LMFA04030005 | LIPID MAPS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:24477830 | Reaxys |
| Citations |
|---|